To include your compound in the COVID-19 Resource Center, submit it here.

MRKAd5 HIV-1 gag/pol/nef subtype B vaccine: Phase IIb data

Researchers at the University of Witwatersrand and colleagues reported data from the double-blind, South African Phase IIb HVTN 503/Phambili trial in 801 evaluable sexually active HIV-1

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE